[HTML][HTML] Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
J Watanabe, T Terazawa, S Yamane, H Kazama… - International Journal of …, 2023 - Springer
Background Safety and effectiveness of aflibercept with 5‐fluorouracil/levofolinate/irinotecan
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
[HTML][HTML] Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
J Watanabe, T Terazawa, S Yamane… - … Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Background Safety and effectiveness of aflibercept with 5‐fluorouracil/levofolinate/irinotecan
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
J Watanabe, T Terazawa, S Yamane… - … journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Safety and effectiveness of aflibercept with 5-fluorouracil/levofolinate/irinotecan
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance.
J Watanabe, T Terazawa, S Yamane… - … Journal of Clinical …, 2023 - search.ebscohost.com
Background: Safety and effectiveness of aflibercept with 5‐fluorouracil/levofolinate/
irinotecan have not been reported in Japanese patients with metastatic colorectal cancer …
irinotecan have not been reported in Japanese patients with metastatic colorectal cancer …
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
J Watanabe, T Terazawa, S Yamane… - … Journal of Clinical …, 2023 - search.proquest.com
Background Safety and effectiveness of aflibercept with 5‐fluorouracil/levofolinate/irinotecan
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance.
J Watanabe, T Terazawa, S Yamane… - … Journal of Clinical …, 2022 - europepmc.org
Background Safety and effectiveness of aflibercept with 5-fluorouracil/levofolinate/irinotecan
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance.
J Watanabe, T Terazawa, S Yamane… - … Journal of Clinical …, 2022 - europepmc.org
Background Safety and effectiveness of aflibercept with 5-fluorouracil/levofolinate/irinotecan
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …
have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a …